All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia

Indian Journal of Cancer

Volumn 41, Issue 3, 2004, Pages 125-128

  Al Bahar, S ^a   Pandita, R ^a   Bavishi, K ^a   Kreze, O ^a  

^a KUWAIT CANCER CONTROL CENTER   (Kuwait)

Author keywords

Acute Promyelocytic Leukemia; All transretinoic acid; Chemotherapy; Kuwait

Indexed keywords

CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; RETINOIC ACID;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CARDIOTOXICITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; FEBRILE NEUTROPENIA; FEMALE; FOLLOW UP; HUMAN; KUWAIT; LIVER TOXICITY; MAINTENANCE THERAPY; MALE; MUCOSA INFLAMMATION; NEPHROTOXICITY; PROMYELOCYTIC LEUKEMIA; PYREXIA IDIOPATHICA; RETINOIC ACID SYNDROME; TREATMENT OUTCOME; TREATMENT PLANNING; VOMITING;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; METHOTREXATE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRETINOIN;

EID: 7644231199     PISSN: 0019509X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Advani SH, Nair R, Bapna A, Gladstone B, Kadam P, Saikia TK, et al. Acute Promyelocytic Leukemia: All-transretinoic acid (ATRA) along with chemotherapy is superior to ATRA alone. Am J Hematol 1999;60:87-93.
2. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, et al. Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Result of a multicentre randomized trial. Blood 1993;82:3241-49.
3. Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, et al. A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 1999;94:1192-2000.
4. Sanz MA, Martin G, Rayon C, Esteve J, Gonzalez M, Diaz-Mediavilla J, et al. A modified AIDA protocol with anthracycline based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RAR alpha positive acute promyelocytic leukemia. Blood 1999;94:3015-21.
5. Frankel SR, Eardley A, Heller G, Berman E, Miller WH Jr, Dmitrsky E, et al. All-transretinoic acid for acute promyelocytic leukemia. Results of the New York study. Ann Intern Med 1994;120:278-86.
6. Mandelli F, Diverio D, Awisati G, Luciano A, Barbui T, Bernasconi C, et al. Molecular remission in PML/RAR alpha - positive acute promyelocytic leukemia by combined all-transretinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell' Adulto and Associazione Italiana di Ematologia ed Oncologica Pediatrica Cooperative Groups. Blood 1997;90:1014-21.
7. Kanamaru A, Takemoto Y, Tanimoto M, Asou N, Kuriyama K, Tsubaki K, et al. All-transrtinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Blood 1995;85:1202-6.
8. Fennaux P, Chomienne C, Degos L. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia. Semin Hematol 2001;38:13-25.
9. Sanz MA, Martin G, Gonzalez M, Leon A, Rayon C, Rivas C, et al. Risk adapted treatment of acute promyelocytic leukemia with all-transretinoic acid and anthracycline monochemotherapy: A multicentre study by the PETHEMA group. Blood 2004;103:1237-43.
10. Tallman MS, Nabhan C, Feusner JH, Rowe JM. Acute promyelocytic leukemia: Evolving therapeutic strategies. Blood 2002;99:759-67.
11. Burnett AK, Grimwade D, Solomon E, Wheatly K, Goldstone AH. Presenting white blood cell count and kinetic of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-transretinoic acid: Result of the randomized MRC trial. Blood 1999;93:4131-43.
12. Soignet SL, Maslak P, Wang ZG, Janwar S, Calleja E, Dardashti LJ, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 1998;399:1341-8.
13. Soignet SL, Frankel SR, Douer D, Tallman MS, Kantarjian H, Calleja E, et al. United States multicentre study of promyelocytic leukemia. J Clin Oncol 2000;18:1295-1300.
14. Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, et al. AIDA (all-transretinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: A Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) pilot study. Blood 1996;88:1390-98.
15. Tallman MS, Anderson JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, et al. Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 2000;95:90-95.
16. DeBotton S, Dombret H, Sanz M, San Miguel J, Caillot D, Zittoun R, et al. Incidence, clinical features and outcome of All-transretinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. Blood 1998;92:2712-8.